CUAMC
OCUL icon

China Universal Asset Management Company’s Ocular Therapeutix OCUL Stock Holding History

China Universal Asset Management Company’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$342K Sell
34,848
-3,783
-10% -$34.3K 0.02% 300
2026
Q1 		$327K Buy
38,631
+2,915
+8% +$27.8K 0.02% 302
2025
Q4 		$434K Sell
35,716
-24,783
-41% -$301K 0.03% 270
2025
Q3 		$707K Sell
60,499
-1,496
-2% -$17.9K 0.06% 207
2025
Q2 		$575K Buy
61,995
+30,460
+97% +$238K 0.05% 231
2025
Q1 		$231K Sell
31,535
-1,801
-5% -$13.8K 0.02% 300
2024
Q4 		$285K Buy
33,336
+3,347
+11% +$32.7K 0.03% 299
2024
Q3 		$261K Buy
29,989
+11,793
+65% +$97.2K 0.03% 278
2024
Q2 		$124K Sell
18,196
-3,003
-14% -$18.5K 0.02% 285
2024
Q1 		$193K Buy
21,199
+12,007
+131% +$85.2K 0.02% 295
2023
Q4 		$41K Buy
9,192
+7,152
+351% +$21.1K 0.01% 387
2023
Q3 		$6.41K Buy
2,040
+1,024
+101% +$4.19K ﹤0.01% 375
2023
Q2 		$5.24K Sell
1,016
-27
-3% -$161 ﹤0.01% 365
2023
Q1 		$5.5K Buy
1,043
+261
+33% +$1.24K ﹤0.01% 357
2022
Q4 		$2.2K Buy
782
+61
+8% +$202 ﹤0.01% 367
2022
Q3 		$3K Buy
+721
New +$3.63K ﹤0.01% 329

Other funds holding OCUL

DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
KIA
Kraematon Investment Advisors Braintree, Massachusetts $134M AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

China Universal Asset Management Company's OCUL Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Ocular Therapeutix (OCUL) stake by 9.8% in Q2 2026, selling an estimated $34.3K and leaving 34,848 shares worth $342K. The position accounts for 0.02% of the portfolio, ranked #300.

China Universal Asset Management Company first reported a position in OCUL in Q3 2022 and has held it in 16 quarters since. The position peaked at $707K in Q3 2025. 36 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • China Universal Asset Management Company held 34,848 shares of Ocular Therapeutix worth $342K as of Q2 2026.
  • China Universal Asset Management Company sold 3,783 Ocular Therapeutix shares in Q2 2026, an estimated $34.3K.
  • Ocular Therapeutix made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #300 holding.
  • China Universal Asset Management Company first reported a position in Ocular Therapeutix in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Ocular Therapeutix position peaked at $707K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.